These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17580365)

  • 1. Revascularization for ischemic LV dysfunction: stents or surgery?
    Thomas M
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):34. PubMed ID: 17580365
    [No Abstract]   [Full Text] [Related]  

  • 2. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
    Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What kind of stent for you today and how would you like it prepared?
    Butman SM
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):173-4. PubMed ID: 17630654
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets.
    Roy P; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Gevorkian N; Satler LL; Kent KM; Suddath WO; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):167-72. PubMed ID: 17503503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetita iuvant.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):468-9. PubMed ID: 18819144
    [No Abstract]   [Full Text] [Related]  

  • 6. Should we routinely use drug-eluting stents for acute myocardial infarction? Let's wait and see.
    Grines CL; Goldstein JA; Safian RD
    JACC Cardiovasc Interv; 2008 Apr; 1(2):136-8. PubMed ID: 19463291
    [No Abstract]   [Full Text] [Related]  

  • 7. Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
    Park SJ
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):13-4. PubMed ID: 21181967
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
    [No Abstract]   [Full Text] [Related]  

  • 9. More openness and a little less strut: two good ideas for stents and the people who implant them.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
    Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
    Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial revascularization: surgery or stenting?
    Wong SH; Wan S; Underwood MJ
    Asian Cardiovasc Thorac Ann; 2007 Jun; 15(3):264-9. PubMed ID: 17541004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 13. The Kounis syndrome in everolimus-eluting stents and paclitaxel-eluting stents.
    Kounis NG; Giannopoulos S; Goudevenos JA
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1076-7; author reply 1078. PubMed ID: 21086494
    [No Abstract]   [Full Text] [Related]  

  • 14. The process of bringing new drug-eluting stents to market will they see the light of day?
    Holmes DR; Patel M
    JACC Cardiovasc Interv; 2008 Oct; 1(5):533-4. PubMed ID: 19463355
    [No Abstract]   [Full Text] [Related]  

  • 15. The gender paradox.
    Presbitero P
    EuroIntervention; 2009 Jan; 4(4):415, 417. PubMed ID: 19284061
    [No Abstract]   [Full Text] [Related]  

  • 16. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
    [No Abstract]   [Full Text] [Related]  

  • 17. The artisan approach for stenting bifurcation lesions.
    Colombo A; Latib A
    JACC Cardiovasc Interv; 2010 Jan; 3(1):66-7. PubMed ID: 20129571
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction.
    Kupferwasser LI; Amorn AM; Kapoor N; Lee MS; Kar S; Cercek B; Dohad S; Mirocha J; Forrester JS; Shah PK; Makkar RR
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):1-8. PubMed ID: 17580366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation myocardial infarction.
    Ziada KM; Charnigo R; Moliterno DJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):39-41. PubMed ID: 21251627
    [No Abstract]   [Full Text] [Related]  

  • 20. A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et al.
    Marx N
    Diab Vasc Dis Res; 2011 Apr; 8(2):173. PubMed ID: 21562069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.